![Jonathan Mow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Mow
Directeur Général chez
PHASEBIO PHARMACEUTICALS, INC.
Profil
Jonathan P.
Mow was the founder of Corus Pharma, Inc., established in 2001, where the titles held included Secretary & VP-Commercial & Business Development from 2001 to 2006.
Current jobs include Chief Executive Officer & Director at PhaseBio Pharmaceuticals, Inc. since 2014, and Chief Executive Officer & Director at Veralox Therapeutics, Inc. since 2023.
Former jobs include Chief Executive Officer at Trefoil Therapeutics, Inc., Director-Worldwide Oncology Marketing at Bristol Myers Squibb Co. from 1995 to 1997, Vice President-Business Development at Amylin Pharmaceuticals, Inc. from 2007 to 2012, and Principal roles at PathoGenesis Corp, Syntex Laboratories, Inc., and Lederle International.
Education history includes undergraduate studies at the University of California, Berkeley, and an MBA from Tepper School of Business.
Postes actifs de Jonathan Mow
| Sociétés | Poste | Début |
|---|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Directeur Général | 01/09/2014 |
Veralox Therapeutics, Inc.
 Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services for clinical stage company | Directeur Général | 20/06/2023 |
Anciens postes connus de Jonathan Mow
| Sociétés | Poste | Fin |
|---|---|---|
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Corporate Officer/Principal | - |
Corus Pharma, Inc.
 Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat needs in the infectious diseases and respiratory areas | Fondateur | 01/01/2006 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/1997 |
Trefoil Therapeutics, Inc.
 Trefoil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company which focuses on the application of novel engineered FGF-1 compounds to treat corneal diseases | Directeur Général | - |
Syntex Laboratories, Inc. | Corporate Officer/Principal | - |
Formation de Jonathan Mow
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
69
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Develops and markets innovative treatments for chronic infectious diseases | Health Technology |
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat needs in the infectious diseases and respiratory areas | Health Technology |
PhaseBio Pharmaceuticals, Inc.
 PhaseBio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapies for cardiovascular diseases | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syntex Laboratories, Inc. | |
Lederle International | |
Tepper School of Business
 Tepper School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trefoil Therapeutics, Inc.
Trefoil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company which focuses on the application of novel engineered FGF-1 compounds to treat corneal diseases | Health Technology |
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services for clinical stage company | Health Technology |
